Geneology International

Tag: Market

  • Herbal Medicine Market Is Expected To Reach around USD

    Herbal Medicine Market Is Expected To Reach around USD






    Farmington, Feb. 07, 2023 (GLOBE NEWSWIRE) — The Global Herbal Medicine Market Size Was Valued At USD 151.91 Billion In 2021. The Market Is Projected To Grow From USD 165.66 Billion In 2022 To USD 347.50 Billion By 2030, Exhibiting a CAGR Of 11.16{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} During The Forecast Period. The COVID-19 pandemic has been shocking and has never happened before. When compared to the time before the pandemic, the demand for herbal medicine is higher than expected in all areas. Our research shows that the global market was 8.46{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} bigger in 2020 than in 2019.

    Herbal medicines come from plants and are used to help with health and skin. Most herbal medicines used in Asia come from Ayurveda and old Chinese medicine.

    Because the COVID-19 virus helped the market do well, there are more worries about health.

    Request Sample Copy of Report “Herbal Medicine  Market – Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2022 to 2030”, published by Contrive Datum Insights.

    Recent Developments:

    • November 2020 – Kunnath Pharmaceuticals, a manufacturer of herbal products from India, launched antiviral immunity booster capsules across India under the brand name ‘Viromune’. With this launch, the company plans to achieve sales of USD 266 million over the next three years.
    • March 2021 – Lotus, one of India’s popular beauty companies, launches the Lotus Botanicals brand. This e-commerce brand allows consumers to order skin and hair care products from Lotus Botanicals only through Lotus Botanicals and other third-party e-commerce channels.

    Segment Overview

    Application Insights

    By use, the largest market share for herbal medicines is in the pharmaceutical and nutraceutical segment. This is because companies that make dietary supplements and alternative medicines need a lot of herbal raw materials. People are moving away from synthetic medicines and towards herbal ones after learning about the long-term benefits of herbal products. Herbal protein powders and products that make you look younger are two popular types of products in the nutraceuticals industry. In the long run, these industries are likely to need more and more herbal products. During the time frame of the forecast, this will help the pharmaceutical and nutraceutical market segment be the most important. The second largest part of the market is made up of products for personal care and beauty. Herbal raw materials are becoming more popular in the cosmetics industry because they are good for the hair, face, and skin in the long run. As more people learn about how good the product is for them in the long run, more and more people are buying herbal cosmetics. Food and drink is a fairly new industry, and people are still getting used to the products. Key food companies are making drinks, juices, and milk products with herbal flavours and selling them as alternatives to regular drinks. Because new, innovative products will be coming out in the next few years, this segment is expected to grow at the fastest rate over the next few years.

    Form Insights

    Tablets and capsules have the most market share because of how they look. There are a lot of capsules and tablets on the market that contain these kinds of medicines. Also, more and more prescriptions are calling for herbal capsules and tablets. Since the pharmaceutical industry is making more herbal products, this market segment is expected to remain the most important during the forecast period.

    The liquid and gel segment has the second-largest share of the market when it comes to form. Liquid and gel products are used in the pharmaceutical, nutraceutical, and food and drink industries. Several companies are making herbal and turmeric drinks and entering the market for liquids.

    Regional Outlook:

    Europe has the biggest market for cosmetics in the world, which is a good place for new companies from developing countries to start. At the same time, beauty and personal care products made with natural ingredients are becoming more popular, and this trend is likely to continue. Based on this demand from European countries, it is likely that Europe will help the market grow a lot in the future. Turmeric is becoming more and more popular in Europe’s market for health products. It is known to have antioxidant and anti-inflammatory properties, so it is used as a supplement and in medical products to improve the immune and digestive systems and overall health. The EU gets most of its turmeric from India, but it also gets some from Thailand, Madagascar, Peru, and Sri Lanka. A big reason why people want turmeric is that people in Europe are living longer. As people in Europe become more health-conscious, the area will grow. Turmeric is a popular spice in the area because it is used in a lot of dishes from different cultures.

    Buy this Premium Research Report@
    https://www.contrivedatuminsights.com/buy/248522/?Mode=PM

    Scope of Report:

    Report Attributes Details
    Growth Rate CAGR of 11.16{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2023 to 2030.
    Revenue Forecast by 2022                        USD 165.66 Billion
    By Application Pharmaceutical & Nutraceutical, Food & Beverages, Personal Care & Beauty Products, Others
    By Form Powder, Liquid & Gel, Tablets & Capsules, Others
    By Companies  Cultivator Natural Products Pvt. Ltd. (India), 21ST Century HealthCare, Inc. (U.S.), Herbalife Nutrition (U.S.), ZeinPharma Germany GmbH (Germany), Blackmores Limited (Australia), Himalaya Global Holdings Ltd. (India), Nutraceutical Corporation (U.S.), Emami Limited (India), Nature’s Answer, LLC. (U.S.), Patanjali Ayurved Limited (India)
    Regions and Countries Covered
    • North America: (US, Canada, Mexico, Rest of North America)
    • Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
    • Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
    • The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
    • Latin America(Brazil, Argentina, Rest of Latin America)
    • Rest Of the World
    Base Year  2022
    Historical Year  2017 to 2022
    Forecast Year  2023 to 2030

    Trends:

    More and more people are taking herbal supplements.

    In the last ten years, herbal medicines and other alternatives to antibiotics have become more and more popular. Both patients and doctors are becoming more and more interested in herbal products. WHO says that 10–50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of people in developed countries use herbal products regularly in some way. The main reason to use herbal products is that they help your body fight off illness better than synthetic drugs. In developing countries like China, Japan, India, Vietnam, South Africa, and Bangladesh, herbal medicines are sometimes the only affordable treatment option. People usually take these medicines for coughs, colds, nervousness, stomach problems, and painful conditions like joint pain, rheumatism, and stiffness. Because herbal supplements are becoming more popular, the market probably has a good chance of growing.

    Driving Factors:

    Herbal ingredients are becoming more and more important in the cosmetics industry, which is a big driver of market growth.

    The cosmetics industry is a good place for exporters of natural ingredients from developing countries who want to grow their businesses in developed regions. More and more beauty companies want to use ingredients that come from nature. This demand is mostly because people are becoming more aware of natural cosmetics and because cosmetics companies are working harder to make herbal ingredients that can replace synthetic ones. As the need for cosmetics and toiletries made with natural ingredients grows, this trend is likely to keep going during the forecast period. In cosmetics, natural ingredients are replacing chemicals made in a lab. This is mostly to meet the needs of consumers and also to move towards raw materials that are better for the environment. People want personal care, beauty, and toiletry products that don’t have chemicals, so the herbal medicine market is likely to grow.

    Restraining Factors:

    Tight rules about how herbal medicines can be used as ingredients in cosmetics will slow the growth of the market.

    Every country has its own rules about how to bring in herbal and natural products and how to use them. WHO says that many countries lack political will, a legal framework, the ability to monitor the safety of the products and how they are used, referral mechanisms between herbal and conventional medical practitioners, information systems, analysis of herbal ingredients, and integration of herbal products into health systems. Because of the things above, it is hard for companies that sell or make herbal products to get into new product markets. There are also different laws and standards that manufacturers and suppliers must follow and accept.

    Key Segments Covered:

    Top Market Players:
    Cultivator Natural Products Pvt. Ltd. (India), 21ST Century HealthCare, Inc. (U.S.), Herbalife Nutrition (U.S.), ZeinPharma Germany GmbH (Germany), Blackmores Limited (Australia), Himalaya Global Holdings Ltd. (India), Nutraceutical Corporation (U.S.), Emami Limited (India), Nature’s Answer, LLC. (U.S.), Patanjali Ayurved Limited (India), and others.

    By Application

    • Pharmaceutical & Nutraceutical
    • Food & Beverages
    • Personal Care & Beauty Products
    • Others

    By Form

    • Powder
    • Liquid & Gel
    • Tablets & Capsules
    • Others

    Regions and Countries Covered

    • North America: (US, Canada, Mexico, Rest of North America)
    • Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
    • Asia-Pacific: (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
    • The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
    • Latin America: (Brazil, Argentina, Rest of Latin America)
    • Rest Of the World

    Check out more related studies published by Contrive Datum Insights:

    • Acne Medicine Market– The global Acne Medicine market size reached US$ 6.1 Billion in 2022. And it is expected to grow at a CAGR of 7.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} during 2022-2230. 
    • E-Prescribing Market – The Global E-Prescribing Market Size Was Estimated At USD 2.89 Billion In 2022 And It Is Anticipated To Witness A CAGR Of 26.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} During The Forecast Period.
    • Nuclear Medicine Imaging Equipment Market – The Global Nuclear Medicine Imaging Equipment Market Is Expected To Grow From USD 2.8 Billion In 2022 And CAGR Of Approximately 4.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} During The Forecast Period 2022-2030.

    Customization of the Report: The report can be customized as per client needs or requirements.
    For any queries, you can contact us on [email protected] or +1 2152974078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

    About Us:
    Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.

    Contact Us:
    Anna B. | Head Of Sales
    Contrive Datum Insights
    Phone: +    91 9834816757 | +1 2152974078
    Email:     [email protected]

    Website:
    https://www.contrivedatuminsights.com
    Contrive Datum Insights Press Releases
    Latest Vantage Market Latest Reports

    Social: Facebook / LinkedIn / Twitter

  • Instantaneous healthcare backed by 5G to drive the Traditional Chinese Medicine Market at a CAGR of 5.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Instantaneous healthcare backed by 5G to drive the Traditional Chinese Medicine Market at a CAGR of 5.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Push Launch

    Published March 3, 2023

    The Regular Chinese Drugs Industry is possible to mature at an impertinent amount shortly. Chabot’s powered by machine understanding is the transformation of the way conversation among sufferers comes about. Device finding out is there to assist radiologists to determine differences in the scans. This, in switch, helps them in diagnosing and detecting well being concerns, that far too, at an early phase. This is the ongoing pattern in the healthcare vertical and the status quo is anticipated to continue to be unchanged even heading forward.

    Standard Chinese Medication (TCM) is a type of option medicine that has been used for around two thousand decades in China. It encompasses a selection of practices this kind of as organic medicine, acupuncture, and massage. TCM has develop into more and more preferred in modern many years, equally in China and in other sections of the globe. This report delivers an overview of the TCM marketplace, like its dimensions, advancement, and vital tendencies.

    Common Chinese medicine is a single of the oldest methods of well being and wellness that has been made use of in China for countless numbers of several years. Other medications generally focus on managing a sickness. But standard Chinese medications goal to increase immune power and glance at the entire effectively-getting. The most prevalent variety of common Chinese medications involves organic goods, acupuncture, and Tai Chi, among other people.

    Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/16219

    In accordance to a most up-to-date report published by PMR, the global conventional Chinese drugs marketplace is predicted to witness a CAGR of more than 5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} over the forecast period of time (2020–2030).

    Company Profiles:

    • Tongrentang
    • Zhongxin Prescription drugs
    • Tianjin Tasly Team
    • Yuannan Baiyao
    • Solstice Medication Organization, Inc.
    • Shanghai Sundise Common Chinese Medicine Co., Ltd
    • China Chinese Drugs Holding Co., Ltd.
    • Hunan goldliloo pharmaceutical Co., Ltd
    • Wanbang Pharma Team Corp.
    • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
    • Pfizer Inc.
    • Eli Lilly and Corporation
    • Novartis AG
    • GlaxoSmithKline PLC
    • Mallinckrodt Prescribed drugs
    • Hisamitsu Pharmaceutical Co., Inc.

    Ask for for Methodology @ https://www.persistencemarketresearch.com/methodology/16219

    Instantaneous healthcare backed by 5G to drive the Traditional Chinese Medicine Market at a CAGR of 5.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

     Key Takeaways from Conventional Chinese Drugs Market place Study   

    • Non-standard Chinese medications is the top phase by products in the world wide conventional Chinese drugs marketplace. The Autism Spectrum disorder (ASD) segment has been getting additional traction in new several years, and is predicted to expand at a price of 6.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} during the forecast time period.
    • North The united states is the major area in the traditional Chinese medicine current market, followed by Europe.
    • East and South Asia, which includes China, South Korea, Japan, India, and ASEAN international locations, is the quickest-expanding region in the regular Chinese drugs market place, thanks enhancing professional medical infrastructure.
    • Tong Ren Tang, Pfizer, and Novartis AG are amongst the foremost gamers in the world-wide common Chinese medicine industry. These providers spend most of their earnings in R&D, and aim on strengthening their distribution channels to maintain a primary position in the classic Chinese medication current market room.
    • 100+ overall health units are partnering with retail chains, supplying medical professional oversights and improved affected person website traffic to retail clinics, and extending health and fitness procedure networks to new individual populations.
    • The COVID-19 pandemic is a trigger for issue, which has deprioritized non-essential professional medical therapies. This will harm the progress of the global common Chinese medicine marketplace in the brief time period.

    “Increasing incidence of ADHD to raise expansion of worldwide traditional Chinese medication market place,” suggests a PMR analyst.

    Obtain Entire Report @ https://www.persistencemarketresearch.com/checkout/16219

    Rising prevalence of ADHD is a big component contributing to income growth of the regular Chinese medication market place throughout the globe. The exact cause of ADHD is nevertheless unclear, whilst genetic affect is observed in most instances.

    As for every facts launched by the Centers for Disorder Control and Avoidance (CDC), approximately 6.1 million (9.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) – 388,000 children aged 2–5 years, 4 million small children aged 6–11 years, and 3 million youngsters aged 12–17 years – have been identified with ADHD in the U.S. In Spain, pooled prevalence of ADHD in a populace of 361,580 representing little ones and adolescents was approximated at 6.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from the last 10 years.

    Prevalence of ADHD is growing at an alarming level, which is predicted to gas income advancement of ADHD therapeutics this kind of classic Chinese medicines, as there is no particular therapy for this dysfunction.

    Product or service Innovation – Important Strategy of Standard Chinese Medicine Sector Players

    Important players in the world-wide common Chinese medicine market are introducing progressive goods to keep their current market share. A patented know-how identified as osmotic controlled launch oral shipping and delivery method (OROS) is made use of in Concerta, made by Johnson & Johnson. It releases an initial dose of methylphenidate within the initially two hrs of ingestion, and when the pill passes through the tummy and gastrointestinal keep track of, water is absorbed, resulting in internal tension, which releases modest amounts of treatment as the pill passes by gut. This know-how was implemented to maintain regularity of enhancement in cognitive overall performance all through the day.

    Obtain Now @ https://www.persistencemarketresearch.com/checkout/16219

    About Us:

    Persistence Industry Investigation is a U.S.-dependent full-services current market intelligence business specializing in syndicated investigate, custom made study, and consulting solutions. Persistence Marketplace Analysis features current market investigation experience throughout the Healthcare, Chemicals and Materials, Know-how and Media, Electricity and Mining, Foodstuff and Beverages, Semiconductor and Electronics, Client Products, and Shipping and Transportation industries. The company attracts from its multi-disciplinary abilities and superior-pedigree staff of analysts to share details that specifically corresponds to clients’ small business requirements.

    Call Us:

    Persistence Industry Study
    Handle – 305 Broadway, 7th Floor, New York Metropolis, NY 10007 United States
    U.S. Ph. – +1-646-568-7751
    Usa-Canada Toll-free of charge – +1 800-961-0353
    Income – [email protected]
    Web site – https://www.persistencemarketresearch.com

    This Push Launch has been composed with the intention of delivering exact marketplace info which will help our visitors to make informed strategic financial commitment conclusions. If you recognize any issue with this written content, make sure you really feel totally free to arrive at us on [email protected]

    Xherald

    Xherald is passionate about supplying extensive protection of international business news. Devoted to producing just about every participant’s notification, it reaches its individual reader. Daily our specialists offer contemporary pertinent details with regards to what is essentially developing in Markets as effectively as Small business. Our headlines are actually quickly paced and extensive. Our distributor listing connects you with model new items or expert services and its market condition from the most powerful firms close to the earth. Xherald is pushed by its 500+ contributors coming from close to the world. Xherald provides local as well as world wide industry intelligence info protection in sectors ranging from health care, IOT, substances and 17 more sectors. Our updates are speedily paced and thorough. The information we present is really a blend of authentic information, community contributions and curated headlines announcements. All of the updates our organization supplies need to go a demanding criterion of genuineness, relevance and importance to our audience.

  • Systemic Lupus Erythematosus Market Size Growing at 7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Systemic Lupus Erythematosus Market Size Growing at 7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}






    LOS ANGELES, March 01, 2023 (GLOBE NEWSWIRE) — The Global Systemic Lupus Erythematosus Market Size accounted for USD 1,951 Million in 2021 and is estimated to achieve a market size of USD 3,517 Million by 2030 growing at a CAGR of 7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2022 to 2030.

    Systemic Lupus Erythematosus Market Research Report Highlights and Statistics:

    • The Global Systemic Lupus Erythematosus Market Size in 2021 stood at USD 1,951 Million and is set to reach USD 3,517 Million by 2030, growing at a CAGR of 7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    • SLE market presents a wealth of opportunities for growth and innovation with its diverse and unique applications, the SLE market is poised for significant growth in the coming years.
    • Growing Prevalence: SLE affects millions of people worldwide and its prevalence is growing, particularly among women of childbearing age.
    • As the number of SLE patients grows, so does the demand for new and effective treatments, driving growth in the Systemic Lupus Erythematosus market.
    • Growing Investment in R&D: Companies and research institutions are investing heavily in the development of new SLE treatments, further fueling the growth of the market.
    • Other trends include the growing focus on personalized medicine and growing use of digital health technologies
    • Key Players: The Systemic Lupus Erythematosus market is dominated by major players such as Pfizer, GlaxoSmithKline, Roche, and AbbVie, among others.

    Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1166

    Systemic Lupus Erythematosus Market Report Coverage:

    Market Systemic Lupus Erythematosus Market
    Systemic Lupus Erythematosus Market Size 2021 USD 1,951 Million
    Systemic Lupus Erythematosus Market Forecast 2030 USD 3,517 Million
    Systemic Lupus Erythematosus Market CAGR During 2022 – 2030 7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}  
    Systemic Lupus Erythematosus Market Analysis Period 2018 – 2030
    Systemic Lupus Erythematosus Market Base Year 2021  
    Systemic Lupus Erythematosus Market Forecast Data 2022 – 2030
    Segments Covered By Drug Classes, By Route of Administration, And By Geography
    Systemic Lupus Erythematosus Market Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    Key Companies Profiled Roche, Sanofi, GlaxoSmithKline, Pfizer, Bayer, Astra Zeneca, Novartis, ImmuPharma, and Aurinia Pharmaceuticals
    Report Coverage Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

    Systemic Lupus Erythematosus Market Overview:

    Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder that affects multiple systems of the body, including the skin, joints, and internal organs. The SLE market is characterized by a growing demand for new and effective treatments, as well as an increased focus on disease management and patient support. The market is poised for growth, with a rising number of SLE patients, increasing investment in R&D, and a growing number of new treatment options in the pipeline.

    One of the key applications of SLE is in the treatment of symptoms associated with the disease, including joint pain and swelling, fatigue, and skin rashes. A number of drugs are available for the treatment of SLE, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressive drugs, and biologic therapies.

    Another unique application of SLE is in the development of personalized medicine, where treatments are tailored to the specific needs of individual patients. This approach is gaining popularity as it offers a more effective and efficient way to manage the disease and improve patient outcomes. Additionally, the use of telemedicine and digital health technologies is also on the rise, allowing patients to monitor their symptoms and receive care remotely, thus increasing access to care and improving patient outcomes.

    Trends in the Systemic Lupus Erythematosus Market:

    • Growing Focus on Personalized Medicine: Personalized medicine is gaining popularity as a more effective and efficient way to manage SLE, with a growing number of new treatments tailored to the specific needs of individual patients.
    • Increased Focus on Patient Outcomes: There is a growing focus on improving patient outcomes and quality of life for SLE patients.
    • Growing Interest in Complementary and Alternative Therapies: There is a growing interest in complementary and alternative therapies as a way to manage SLE symptoms and improve patient outcomes.
    • Rising Demand for Disease Management Programs: There is a growing demand for disease management programs that help patients to manage their SLE symptoms and improve their quality of life.
    • Increased Collaboration between Industry and Academia: There is an increased focus on collaboration between industry and academia in the development of new SLE treatments.
    • Advances in Biologic Therapies: Biologic therapies are becoming increasingly popular as a treatment option for SLE, due to their effectiveness and ability to target specific aspects of the disease.

    Systemic Lupus Erythematosus Market Dynamics:

    • Growing Demand for New Treatments: As the number of SLE patients grows, so does the demand for new and effective treatments.Increased Awareness: There is an increased focus on disease awareness, education, and support for SLE patients.
    • Growing Use of Digital Health Technologies: The use of telemedicine and digital health technologies is on the rise, allowing patients to monitor their symptoms and receive care remotely.
    • Growing Interest in Patient-Centered Care: There is a growing interest in patient-centered care, with a focus on improving the patient experience and ensuring that patients have access to the care they need.
    • Advances in Clinical Trials: Clinical trials are becoming increasingly sophisticated, with a focus on improving patient outcomes and the development of new treatments.
    • Growing Importance of Patient Advocacy: Patient advocacy is becoming increasingly important, with patient organizations and advocacy groups working to raise awareness and support for SLE patients.

    Growth Hampering Factors in the Market for Systemic Lupus Erythematosus:

    • Limited Understanding of the Disease: Despite advances in research, there is still a limited understanding of SLE, which makes it challenging to develop new treatments and improve patient outcomes.
    • Limited Effective Treatments: Currently, there is no cure for SLE, and available treatments are not always effective for all patients.
    • High Cost of Treatments: The cost of SLE treatments can be prohibitively expensive for many patients, which may limit their access to care.
    • Side Effects of Treatments: Some SLE treatments can have serious side effects, which may discourage patients from seeking care.
    • Difficulty in Diagnosing SLE: SLE can be difficult to diagnose, which may lead to delayed treatment and poor patient outcomes.
    • There may be stigma and discrimination associated with SLE, which may discourage patients from seeking care and treatment.
    • Limited access to care and awareness about SLE, particularly among healthcare providers, which may result in misdiagnosis and delayed treatment.

    Check the detailed table of contents of the report @

    https://www.acumenresearchandconsulting.com/table-of-content/systemic-lupus-erythematosus-market

    Market Segmentation:

    By Drug Classes

    • NSAIDs
    • Antimalarials
    • Corticosteroids
    • Immunosuppressants
    • Biologics

    By Route of Administration

    • Oral
    • Intravenous
    • Subcutaneous

    Systemic Lupus Erythematosus Market Overview by Region:

    North America’s Systemic Lupus Erythematosus market share is the highest globally with the United States being the largest contributor to the region’s market growth. The presence of a large patient pool, favorable reimbursement policies, and high healthcare spending are some of the key drivers of the SLE market in North America.

    The Asia-Pacific region’s Systemic Lupus Erythematosus Market share is also huge and is rapidly growing, with significant growth opportunities in countries such as China, India, and Japan. The increasing prevalence of SLE, the growing healthcare sector, and the rising middle-class population are some of the key factors driving the SLE market in Asia-Pacific.

    Europe is another key market for Systemic Lupus Erythematosus, with significant growth opportunities in countries such as Germany, France, and the United Kingdom. The increasing awareness about SLE, the availability of advanced treatments, and the supportive regulatory environment are some of the key factors driving the SLE market in Europe.

    The South American and MEA regions have a smaller Systemic Lupus Erythematosus market share. The growing healthcare sector, and the rising middle-class population are some of the key factors driving the SLE market in the said regions.

    Buy this premium research report –

    https://www.acumenresearchandconsulting.com/buy-now/0/1166

    Systemic Lupus Erythematosus Market Key Players:

    The Systemic Lupus Erythematosus (SLE) market is highly competitive, with a large number of players operating in the market. Some of the key players in the SLE market include Pfizer, Roche, GlaxoSmithKline, Sanofi, AbbVie, Novartis, Merck & Co., Bristol-Myers Squibb, Celgene, Janssen Global Services, LLC, Eli Lilly and Company, UCB, AstraZeneca, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Astellas Pharma, Inc., Biotest AG, and Coherus BioSciences. These players are focused on developing innovative solutions for SLE patients, such as new drugs, diagnostic tools, and patient-centered solutions, to improve patient outcomes and increase their market share.

    Browse More Research Topic on Healthcare Sector Related Reports:

    The Global Feminine Hygiene Products Market Size is valued at USD 39,107 Million in 2021 and is projected to reach a market size of USD 69,853 Million by 2030; growing at a CAGR of 6.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}.

    The Global Walking Assist Devices Market accounted for USD 6,210 Million in 2021 and is expected to reach the market value of USD 8,711 Million by 2030 at a CAGR of 4.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} during the forecast period from 2022 to 2030.

    The Global Healthcare Smart Beds Market size accounted for USD 561 Million in 2021 and is estimated to reach USD 1,166 Million by 2030.

    About Acumen Research and Consulting:

    Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

    For Latest Update Follow Us on Twitter , Instagram and LinkedIn

    Contact Us:

    Mr. Richard Johnson

    Acumen Research and Consulting

    USA: +13474743864

    India: +918983225533

    E-mail: [email protected]

  • Humana Reveals Plans To Exit Employer-Based Insurance Market

    Humana Reveals Plans To Exit Employer-Based Insurance Market

    News retailers report on a new technique from well being insurance company Humana: it will get up to two decades to exit the employer-centered coverage business enterprise, and alternatively concentration on govt-backed systems like Medicare Edge. Amazon, SimpliFed, DaVita, Teledoc, and a lot more are also in the news.


    AP:
    Insurance company Humana Lays Out Employer-Sponsored Coverage Exit

    The health insurance provider Humana will cease delivering employer-sponsored industrial coverage as it focuses on bigger components of its business, like Medicare Gain. The insurance provider reported Thursday it will depart the business enterprise above the future 18 to 24 months. It includes healthcare protection presented through non-public companies and for federal governing administration workforce. (Murphy, 2/23)

    Meanwhile, in other industry information —


    Fierce Health care:
    Teladoc Sinks $13.7B Reduction In 2022 Tied To Plummeting Value Of Livongo Acquisition

    Teladoc Health noted a historic loss of $13.7 billion in 2022, mainly from a publish-off similar to the plummeting value of its Livongo acquisition. The telehealth company pulled in $2.4 billion in 2022 revenue, up 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from $2 billion in income the prior year, executives described during its fourth-quarter earnings simply call on Wednesday. By comparison, in 2021, Teladoc posted a internet reduction of $429 million. (Landi, 2/23)


    The Wall Road Journal:
    Waning Covid Fears Thrust Test Maker Lucira To File For Personal bankruptcy

    Lucira Health Inc., a publicly traded maker of at-property Covid-19 tests kits, has submitted for individual bankruptcy, indicating an easing of pandemic restrictions has lowered demand for its items. Lucira, which lists $145.9 million in property and $84.7 million in credit card debt, claimed Wednesday it will glimpse for a customer whilst continuing to serve consumers during chapter 11 proceedings in U.S. Bankruptcy Court in Wilmington, Del. (Yerak, 2/23)


    The Wall Avenue Journal:
    Wall Road Backs New Class Of Psychedelic Medications

    Transcend Therapeutics Inc. lifted $40 million from venture-funds buyers in January to establish a article-traumatic stress problem treatment that its 29-yr-old CEO Blake Mandell suggests would involve about 50 percent the quantity of treatment as MDMA, or ecstasy, a well-known hallucinogen. Gilgamesh Prescription drugs Inc. and Lusaris Therapeutics Inc. have declared money raises of about $100 million due to the fact November for very similar merchandise addressing melancholy.  (Wirz, 2/23)


    St. Louis Community Radio:
    Wash U Medicine And Race Discussion board To Focus On Well being Disparities

    Health professionals and scholars in the St. Louis region say professional medical gurus will have to acknowledge the area’s racist history to enable do away with health and fitness treatment inequities. St. Louis’ record of racism, well being disparities and the use of activism and art in drugs are between the subjects that researchers, doctors, students and neighborhood leaders will focus on Saturday at the Medication, Race, and Ethnicity in St. Louis discussion board at Washington University in St. Louis. (Henderson, 2/24)

    On new Food and drug administration approvals for therapies —


    Reuters:
    U.S. Food and drug administration Approves Sanofi’s Bleeding Disorder Treatment

    U.S. overall health regulators have accredited Sanofi SA’s remedy to address a form of inherited bleeding condition regarded as hemophilia A, the French drugmaker mentioned on Thursday, and expects to launch it in the United States in April. With the Food and Drug Administration’s approval, Sanofi’s substitution treatment – brand name named Altuviiio – enters a sector dominated by rivals like Shire, Bayer AG and Novo Nordisk which sell variable replacement therapies that have been the normal therapy for many years. (Roy and Mandowara, 2/23)


    This is aspect of the KHN Morning Briefing, a summary of wellbeing policy coverage from main news businesses.Signal up for an e-mail membership.

  • [2023-2032] Global Cannabidiol Oil Market and Cannabidiol (CBD) Market are Set to Boom at a CAGR of 31.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} & 15.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Resp. | CBD & CBD Oil Industry Size, Share, Trends, Demands, Growth and Future Prospects

    [2023-2032] Global Cannabidiol Oil Market and Cannabidiol (CBD) Market are Set to Boom at a CAGR of 31.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} & 15.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Resp. | CBD & CBD Oil Industry Size, Share, Trends, Demands, Growth and Future Prospects

    Extrapolate

    Extrapolate

    Discover the future of the growing Cannabidiol (CBD) Oil Market and Cannabidiol Market with our latest research report. With a projected market size of over $6.77 billion & $25.15 billion, join the booming market and explore its potential.

    Dubai, UAE, Feb. 02, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD) Oil Market Report 2023-2032:

    As per the recent market research report published by Extrapolate, the global Cannabidiol (CBD) Oil Market to generate a revenue of over USD 6.77 billion by 2032 from USD 580 million in 2022 at a CAGR of 31.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2023 to 2032.

    As the demand for CBD products rises, the Cannabidiol (CBD) Oil Market is expected to expand rapidly over the next few years. This rapid growth is largely driven by the increasing awareness and acceptance of CBD oil, as well as changing consumer preferences and attitudes toward CBD products. The rising popularity of CBD oil is due to a number of factors, including its potential health benefits. As per Extrapolate,  it has been witnessed that CBD oil may further help reduce inflammation, alleviate pain, reduce anxiety and depression, and even help fight cancer. Additionally, CBD oil has been utilized to treat a variety of skin conditions, including acne and eczema.

    The market is further fueled by the growing number of CBD-infused products available. From tinctures, capsules, and gummies to lotions, oils, and even pet products—there is a dizzying array of options when it comes to CBD-related products. Furthermore, new and innovative products are constantly being released. In addition to the obvious medical applications, the CBD oil market is also benefitting from the trend of people looking for natural alternatives to traditional medications. Many consumers find CBD oil to be a more palatable option than pharmaceuticals, and this has driven the growth of the industry even further.

    Get Sample Copy of the Report @ https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/cannabidiol-oil-cbd-market/87381

    The global Cannabidiol (CBD) Oil market is segment as follows:

    Segmentation By Type

    Segmentation By End-Use

    Pharmaceutical Companies to Remain the Largest End-Users in the Cannabidiol (CBD) Oil Market

    The current market for CBD oil is primarily dominated by pharmaceutical companies, which account for the majority of sales. Pharmaceutical companies are attracted to the industry due to its low cost of entry, high margins, and potential for growth. Moreover, they have added advantage over other players in the market due to their extensive experience with manufacturing and distributing drugs. This expertise gives them a greater degree of control over production costs, which they can then pass on to consumers with competitive pricing.

    The demand for CBD oil is expected to increase over the next few years, driven by the increasing acceptance of CBD as a potential treatment for a number of medical conditions.

    Have an Inquiry? Get in Touch with us @ https://www.extrapolate.com/enquire/healthcare-medical-devices-biotechnology/cannabidiol-oil-cbd-market/87381

    Segmentation By Distribution Channel

    • B2B

    • Hospital

    • Online Stores

    • Retail Stores

    B2B Distribution to Continue Holding Its Dominance over Global Cannabidiol (CBD) Oil Market

    In terms of B2B distribution, there is strong demand for CBD oil from major buyers such as distributors, retailers, and medical professionals. It allows for bulk purchasing and wholesale pricing, creating long-term partnerships, and providing access to a wider range of products. Additionally, B2B helps ensure product quality and safety by allowing businesses to access information about the source and production process.

    Wherein, distributors play an important role in ensuring that products reach the end consumer in a timely and efficient manner. Retailers provide CBD products to consumers through brick-and-mortar stores and online platforms. Medical professionals are utilizing CBD for therapeutic purposes, which is driving the demand for these products. In addition, businesses in the hospitality industry are rapidly using CBD-infused products for their calming and relaxing effects.

    Furthermore, the production of CBD-infused products is increasing as manufacturers take advantage of the growing demand for these products. Companies have started to invest in research and development, as well as marketing, to gain a competitive edge in the cannabidiol oil market. Additionally, there is strong demand for CBD oil from countries such as Canada, the US, and Australia, where the legal status of CBD is more favorable.

    Purchase this Premium Research Report @ https://www.extrapolate.com/complete-checkout-buy/87381

    Competitve Landscape:

    The presence of several large players in the region is also contributing to the growth of the CBD oil industry. Major companies such as Cannoid, LLC, Endoca, and Elixinol are investing heavily in research and development, as well as marketing and production capabilities, in order to capitalize on the growing demand for CBD products.

    Key Players in the Cannabidiol Oil Market

    Download Free Sample PDF of this Report – (Including Full TOC, List of Tables & Figures, Chart): https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/cannabidiol-oil-cbd-market/87381

    North America to Remain the Largest Consumer and Revenue Generating Region

    North America is expected to remain the largest consumer and revenue-generating region in the global CBD oil market over the forecast period. It is gaining momentum in the region due to the increasing awareness about the therapeutic and medicinal benefits of cannabidiol (CBD). The growing acceptance of CBD as an alternative form of relief from chronic conditions such as anxiety, pain, seizures, and insomnia is driving demand for these products, especially in the US. Furthermore, the increasing popularity of CBD-infused cosmetics and beauty products is also driving the market forward. As more people become aware of the potential health benefits of CBD, the demand is only expected to increase further in the North American CBD Oil Market.

    Apart from this, countries such as Canada, Mexico, and Colombia are rapidly legalizing the use of medical marijuana, which is further boosting the market in the region. Some countries even allow CBD products to be sold in pharmacies and other retail outlets. These changes are driving consumer demand, especially among individuals looking for natural alternatives in place of traditional medications.

    Major Points from TOC:

    Chapter 1. Executive Summary
    Chapter 2. Research Methodology
    Chapter 3. Market Outlook
    Chapter 4. COVID-19 Impact on Cannabidiol (CBD) Oil Market
    Chapter 5. Global Cannabidiol (CBD) Oil Market Overview, By Type, 2018 – 2032 (USD Million)
    Chapter 6. Global Cannabidiol (CBD) Oil Market Overview, By End-Use, 2018 – 2032 (USD Million)
    Chapter 7. Global Cannabidiol (CBD) Oil Market Overview, By Distribution Channel, 2018 – 2032 (USD Million)
    Chapter 8. Global Cannabidiol (CBD) Oil Market Overview, By Geography, 2018 – 2032 (USD Million)

    Chapter 9. North America Cannabidiol (CBD) Oil Market Overview, By Countries, 2018 – 2032 (USD Million)

    ….Continued

    Part II: Cannabidiol (CBD) Market Outlook To 2032:

    The Cannabidiol (CBD) Industry has been experiencing tremendous growth in recent times. According to a recent market research analysis by Extrapolate, the global Cannabidiol (CBD) Market was valued at USD 6.06 billion in 2022 and is expected to reach a valuation of USD 25.15 billion by 2032 at a CAGR of 15.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} during the forecast period.

    In 2018, the United States incorporated The Farm Bill to legalize CBD, hemp and its other derivatives. This has led to an increase in demand for CBD products. As per Extrapolate’s recent study, the global CBD market valuation has expanded by 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} since the declaration of the 2018 Farm Bill. In addition, numerous studies have confirmed that CBD has medical potential for treating various conditions like chronic pain, inflammation, anxiety, depression, epilepsy, and more.

    Request Sample PDF of the Report: https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/cannabidiol-cbd-market-report/33239

    CBD’s drug delivery system has improved over time to make it more bioavailable, providing consumers a consistent and dependable dosage. The global CBD market is expected to grow significantly in the coming years due to increased demand and the entry of new market players. This growth will also be driven by supportive regulations, investment in research and development, and the launch of new products.

    CBD’s popularity has skyrocketed in recent years because of its therapeutic properties and medicinal benefits. As a non-psychoactive compound, it does not produce the intoxicating effects of marijuana, making it a safer and more appealing option for people seeking relief from various ailments. The key factors driving demand for CBD include its perceived medical benefits and the updated legal status. With its increasing availability, more people are choosing it as a natural remedy over traditional pharmaceuticals, and its legal status has become more accepted in many countries and states.

    Competitive Landscape:

    The global cannabidiol market is highly fragmented, with prominent players such as CannaVEST, Kazmira, CW Hemp/CW Botanicals, Freedom Leaf, Endoca, and Medical Marijuana, Inc., among others. These companies are engaged in offering a wide range of CBD-based products in various forms, such as oils, topicals, edibles, tinctures, capsules, and beverages. Furthermore, these companies are focusing on expanding their product portfolios by introducing new product offerings.

    Have an Enquiry? Talk to our Analyst @ https://www.extrapolate.com/enquire/healthcare-medical-devices-biotechnology/cannabidiol-cbd-market-report/33239

    Online Sales of CBD Products is Gaining Momentum in North America and Europe 

    Online sales of cannabidiol (CBD) products have seen a strong momentum of growth in North America and Europe. This is mainly due to the increasing awareness and acceptance of CBD products in these regions and the relaxation of certain regulations preventing its use. In North America, the United States captured the largest market for CBD products, accounting for over 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the total market share. The increasing demand for CBD products, coupled with the growing acceptance among consumers, has contributed to the growth of online sales of CBD products in the US.

    Meanwhile, Canada is also emerging as a lucrative market for CBD products, with sales of legal CBD products estimated to reach USD 560 million by 2028.

    In Europe, the UK is one of the leading markets for CBD products. According to The Centre for Medical Cannabis, the Europe CBD market size was valued at 2.53 billion in 2021. This is mainly due to the relaxed regulations regarding the use of CBD products in the UK, as well as the increasing awareness of the health benefits offered by CBD products. Meanwhile, Germany and Switzerland are two of Europe’s leading markets for CBD products.

    Purchase this Premium Research Report @ https://www.extrapolate.com/complete-checkout-buy/33239

    The global Cannabidiol (CBD) Market is segmented as follows:

    Segmentation (by Type)

    • Hemp-derived Type

    • Marijuana-derived Type

    Marijuana Segment Captured Over 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Revenue of the Global Cannabidiol Market

    The global cannabidiol (CBD) market has witnessed significant revenue growth in the past few years. In 2022, the marijuana segment captured over 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the total market revenue, driven by increasing demand for cannabis-based products and the expansion of online retail channels worldwide. This is due to the rising awareness among consumers of the therapeutic potential of CBD-derived products, which has led to an increase in product demand. Additionally, rapid legislative changes in the United States and other countries have made hemp-derived CBD legal, and this has created further opportunities for the industry.

    In the United States, marijuana has been federally legalized for medical and recreational use. This has created a conducive regulatory environment for the sale, manufacture, and distribution of cannabis products in the country.

    Going forward, the introduction of new technological innovations and the proliferation of digital marketing strategies are expected to further drive the marijuana segment’s market potential. The emergence of new forms of marijuana consumption, such as edibles, beverages, and vape pens, is likely to open up a range of opportunities for the industry. Moreover, ongoing efforts by companies to create a more open cannabis trade will lead to further growth in the coming years.

    Download Free Sample PDF of this Report – (Including Full TOC, List of Tables & Figures, Chart)

    Segmentation (by Application)

    • Pharmaceuticals Industry

    • Food Industry

    • Cosmetics Industry

    • Other

    Key Points From TOC:
    1 Research Methodology and Statistical Scope
    2 Cannabidiol (CBD) Market Overview
    3 Cannabidiol (CBD) Market Competitive Landscape
    4 Cannabidiol (CBD) Industry Chain Analysis
    5 The Development and Dynamics of Cannabidiol (CBD) Market
    6 Cannabidiol (CBD) Market Segmentation by Type
    7 Cannabidiol (CBD) Market Segmentation by Application
    8 Cannabidiol (CBD) Market Segmentation by Region
    9 Key Companies Profiled
    10 Cannabidiol (CBD) Market Forecast by Region
    11 Forecast Market by Type and by Application (2023-2032)
    12 Conclusion and Key Findings

    Browse Complete TOC: https://www.extrapolate.com/toc/healthcare-medical-devices-biotechnology/cannabidiol-cbd-market-report/33239

    About Us:

    Extrapolate is a Global Market Research, Advisory, and Consulting firm that works closely with Industry experts from various industries to bring the latest and most accurate research reports.

    In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets – not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.

    CONTACT: Extrapolate Phone: (+1) 888 328 2189 E-mail: [email protected] Website: https://www.extrapolate.com Blog: https://www.extrapolate.com/blog
  • 3D Printing Revolutionizing the Orthopedic Splints and Casts Market with Tremendous Opportunities, the Market to Mark USD 3.34 Billion by 2027

    3D Printing Revolutionizing the Orthopedic Splints and Casts Market with Tremendous Opportunities, the Market to Mark USD 3.34 Billion by 2027

    CHICAGO, Jan. 18, 2023 /PRNewswire/ — According to Arizton’s latest research report, the global orthopedic splints and casts market will grow at a CAGR of 6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2021-2027. Growing demand for 3D printed casts & splints, availability of a wider product portfolio of splints & casts by vendors, and introduction of spray-based form splints are significant growth opportunities in the orthopedic splints & casts market.

    Orthopedic Splints And Casts Market

    Orthopedic Splints And Casts Market

    3D printing is an evolving technology that has a potential application in treating pediatric forearm fractures. The clinical outcomes were excellent at the latest follow-up, at least one-year post-injury. 3D-printed casts may allow for greater patient satisfaction and reduced complications in adult and pediatric patients as this technology becomes further integrated into medicine, specifically orthopedics. Orthopedic surgeons may benefit from familiarizing themselves with the potential of 3D printing technology and its current applications and devising future applications for clinical practice. Many emerging companies are developing 3D-printed splints & casts. For instance, ActiveArmour, a leading global company in 3D printed casting/splinting, designs a wholly individualized and fitted splint based on the physician’s specific positioning and instructions for each patient’s unique needs. Another company in the 3D printed splints & casts market, Fix It, designs 3D printed splints made from biodegradable plastic as an alternative to traditional casts. Thus, emerging 3D printed splints/casts products will accelerate the orthopedic splint & casts market.

    GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET REPORT SCOPE

    Report Attributes

    Details

    Market Size (2027)

    USD 3.34 Billion

    Market Size (2021)

    USD 2.34 Billion

    CAGR (2021-2027)

    6.06 {fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Base Year

    2021

    Forecast Year

    2022-2027

    Market Segments

    Product, Material, Body Part, End User, and Geography

    Geographic Analysis

    North America, Europe, APAC, Latin America, and Middle East & Africa

    Key Leading Countries

    China, India, Japan, South Korea, Australia, Germany, Italy, Spain, France, the UK, the US, Canada, Brazil, Mexico, Argentina, Turkey, South Africa, South Arabia, Egypt, and Nigeria

    Key Prominent Players

    Essity Medical Solutions, 3M, Enovis, Breg, DeRoyal Industries, Bauerfeind, ALCARE, Frank Stubbs Company, Weber Orthopedic LP. DBA Hely & Weber, medi, Carolina Narrow Fabric, Thuasne Group, Trulife, Tynor, Orthosys, DUK-IN, Performance Health, AliMed, Lohmann & Rauscher, Elite Orthopaedics, Allard USA, BraceAbility, VISSCO REHABILITATION, Bird & Cronin, Datt Mediproducts, and Prime Medical

    Page Number

    292

    Market Dynamics

    • Increasing Target Patient Population

    • Rising Adoption of Fiberglass Casts & Splints

    • Paradigm Shift Towards Outpatient Orthopedic Care

    Customization Request

    If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3642

     

    Click Here to Download the Free Sample Report

    APAC TO OBSERVE FASTEST GROWTH IN THE ORTHOPEDIC SPLINTS AND CASTS MARKET

    APAC is leading the orthopedic splints & casts market, contributing to increased MSDs incidence, a growing aging population, and related health conditions. APAC accommodates many regional and local orthopedic splints & cast manufacturers actively developing innovative orthopedic splints & casts at affordable costs. China, Japan, Australia, India, and South Korea are major countries contributing to the exponential growth of the market in this region.

    APAC has become an appealing market for global players and expansionary private investments that can effectively support innovation while driving consumption and capitalizing on demographic and emerging consumer trends. Overall, the rapidly growing life expectancy, economic growth, and more effective treatment procedures offer long-term growth opportunities for the APAC orthopedic splints & casts market.

    Moreover, introducing innovative concepts around orthopedic medicine in the orthopedic splints and casts market can be a game changer because of several benefits over conventional orthopedic splints and casts. The emergence of the spray-based form splint is offering leading players and start-ups the opportunity to develop orthopedic splints & casts with the help of polyurethane spray.

    RECENT DEVELOPMENTS IN THE GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET

    • In early 2019, Enovis (formulary known as Colfax) completed the acquisition of DJO for around USD 3.15 billion. With this acquisition, Colfax aimed to create a new platform for itself in the orthopedic market, as DJO was one of the leading companies in braces and support devices.

    • Breg, a leading orthopedic and billing services company, partnered with its UK distributor, Joint Operations, to expand the supply of high-quality orthopedic products to the UK/Ireland market in July 2020.

    COMPETITIVE OVERVIEW

    The orthopedic splints & casts market is pursuing various strategies to provide the impetus for growth over the next few years. These market participants adopt cooperation, partnerships, mergers & acquisitions, and product launches. Due to these strategies, the orthopedic splints & casts market has the potential to have significant growth opportunities. For instance, Breg partnered with the Australian distributor Club Warehouse to expand its supply of high-quality orthopedic products to the Australian market.

    KEY COMPANY PROFILES

    MARKET SEGMENTATION

    Product

    Material

    Body Part

    End User

    Geography

    • APAC

    • Europe

    • North America

    • Latin America

    • Middle East & Africa

    Click Here to Download the Free Sample Report

    CHECK OUT SOME OF THE TOP-SELLING RELATED RESEARCH REPORTS:

    Bone Growth Products Market – The global bone growth product market is expected to reach USD 1.4 billion in 2027.

    Orthopedic Braces and Supports Market – The orthopedic braces & supports is expected to reach USD 4.42 billion by 2027.

    Interbody Spinal Implants Market – The interbody spinal implants market is estimated to reach USD 2.1 billion by 2027.

    Medical Exoskeleton Market – The global medical exoskeleton market size is expected to reach USD 3.81 billion by 2027.

    TABLE OF CONTENT

    1 RESEARCH METHODOLOGY

    2 RESEARCH OBJECTIVES

    3 RESEARCH PROCESS

    4 SCOPE & COVERAGE

    4.1 MARKET DEFINITION

    4.1.1 INCLUSIONS

    4.1.2 EXCLUSIONS

    4.1.3 MARKET ESTIMATION CAVEATS

    4.2 BASE YEAR

    4.3 SCOPE OF THE STUDY

    4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

    5 REPORT ASSUMPTIONS & CAVEATS

    5.1 KEY CAVEATS

    5.2 CURRENCY CONVERSION

    5.3 MARKET DERIVATION

    6 MARKET AT A GLANCE

    7 PREMIUM INSIGHTS

    7.1 MARKET OVERVIEW

    7.1.1 MARKET DYNAMICS

    7.1.2 MARKET SEGMENTATION

    7.1.3 VENDOR ANALYSIS

    8 INTRODUCTION

    8.1 OVERVIEW

    8.1.1 MUSCULOSKELETAL DISORDERS STATISTICS

    9 MARKET OPPORTUNITIES & TRENDS

    9.1 GROWING DEMAND FOR 3D-PRINTED CASTS & SPLINTS

    9.2 AVAILABILITY OF WIDER PRODUCT PORTFOLIO OF SPLINTS & CASTS BY VENDOR

    9.3 INTRODUCTION OF SPRAY-BASED FORM SPLINTS

    10 MARKET GROWTH ENABLERS

    10.1 INCREASING TARGET PATIENT POPULATION

    10.2 RISING ADOPTION OF FIBERGLASS CASTS & SPLINTS

    10.3 PARADIGM SHIFT TOWARD OUTPATIENT ORTHOPEDIC CARE

    11 MARKET RESTRAINTS

    11.1 COMPLICATIONS ASSOCIATED WITH THE USE OF SPLINTS AND CASTS

    11.2ALTERNATIVE TREATMENT OPTIONS FOR ORTHOPEDIC DISORDERS & CONDITIONS

    11.3 LACK OF PRODUCT DIFFERENTIATION COUPLED WITH PRICING PRESSURE

    12 MARKET LANDSCAPE

    12.1 MARKET OVERVIEW

    12.2 MARKET SIZE & FORECAST

    12.2.1 INSIGHT BY PRODUCT SEGMENTATION

    12.2.2 INSIGHT BY MATERIAL SEGMENTATION

    12.2.3 INSIGHT BY BODY PART SEGMENTATION

    12.2.4 INSIGHT BY END-USERS SEGMENTATION

    12.2.5 INSIGHT BY GEOGRAPHY SEGMENTATION

    12.3 FIVE FORCES ANALYSIS

    12.3.1 THREAT OF NEW ENTRANTS

    12.3.2 BARGAINING POWER OF SUPPLIERS

    12.3.3 BARGAINING POWER OF BUYERS

    12.3.4 THREAT OF SUBSTITUTES

    12.3.5 COMPETITIVE RIVALRY

    13 PRODUCT

    13.1 MARKET SNAPSHOT & GROWTH ENGINE

    13.2 MARKET OVERVIEW

    13.3 CASTS

    13.3.1 MARKET OVERVIEW

    13.3.2 MARKET SIZE & FORECAST

    13.3.3 MARKET BY GEOGRAPHY

    13.4 SPLINT

    13.4.1 MARKET OVERVIEW

    13.4.2 MARKET SIZE & FORECAST

    13.4.3 MARKET BY GEOGRAPHY

    14 MATERIALS

    14.1 MARKET SNAPSHOT & GROWTH ENGINE

    14.2 MARKET OVERVIEW

    14.3 SYNTHETIC SPLINTS & CASTS

    14.3.1 MARKET OVERVIEW

    14.3.2 MARKET SIZE & FORECAST

    14.3.3 MARKET BY GEOGRAPHY

    14.4 PLASTER OF PARIS SPLINTS & CASTS

    14.4.1 MARKET OVERVIEW

    14.4.2 MARKET SIZE & FORECAST

    14.4.3 MARKET BY GEOGRAPHY

    15 BODY PART

    15.1 MARKET SNAPSHOT & GROWTH ENGINE

    15.2 MARKET OVERVIEW

    15.3 UPPER BODY

    15.3.1 MARKET OVERVIEW

    15.3.2 MARKET SIZE & FORECAST

    15.3.3 MARKET BY GEOGRAPHY

    15.4 LOWER BODY

    15.4.1 MARKET OVERVIEW

    15.4.2 MARKET SIZE & FORECAST

    15.4.3 MARKET BY GEOGRAPHY

    16 END-USER

    16.1 MARKET SNAPSHOT & GROWTH ENGINE

    16.2 MARKET OVERVIEW

    16.3 ORTHOTIC & ORTHOPEDIC CLINICS

    16.3.1 MARKET OVERVIEW

    16.3.2 MARKET SIZE & FORECAST

    16.3.3 MARKET BY GEOGRAPHY

    16.4 HOSPITAL

    16.4.1 MARKET OVERVIEW

    16.4.2 MARKET SIZE & FORECAST

    16.4.3 MARKET BY GEOGRAPHY

    16.5 OTHERS

    16.5.1 MARKET OVERVIEW

    16.5.2 MARKET SIZE & FORECAST

    16.5.3 MARKET BY GEOGRAPHY

    17 GEOGRAPHY

    17.1 MARKET SNAPSHOT & GROWTH ENGINE

    17.2 GEOGRAPHIC OVERVIEW

    18 APAC         

    18.1 MARKET OVERVIEW

    18.2 MARKET SIZE & FORECAST

    18.3 APAC: PRODUCT SEGMENTATION

    18.4 APAC: MATERIAL SEGMENTATION

    18.5 APAC: BODY PART SEGMENTATION

    18.6 APAC: END USER SEGMENTATION

    18.7 KEY COUNTRIES

    18.7.1 CHINA: MARKET SIZE & FORECAST

    18.7.2 INDIA: MARKET SIZE & FORECAST

    18.7.3 JAPAN: MARKET SIZE & FORECAST

    18.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

    18.7.5 AUSTRALIA: MARKET SIZE & FORECAST

    19 EUROPE

    19.1 MARKET OVERVIEW

    19.2 MARKET SIZE & FORECAST

    19.3 EUROPE: PRODUCT SEGMENTATION

    19.4 EUROPE: MATERIAL SEGMENTATION

    19.5 EUROPE: BODY PART SEGMENTATION

    19.6 EUROPE: END-USER SEGMENTATION

    19.7 KEY COUNTRIES

    19.7.1 GERMANY: MARKET SIZE & FORECAST

    19.7.2 FRANCE: MARKET SIZE & FORECAST

    19.7.3 THE UK: MARKET SIZE & FORECAST

    19.7.4 ITALY: MARKET SIZE & FORECAST

    19.7.5 SPAIN: MARKET SIZE & FORECAST

    20 NORTH AMERICA

    20.1 MARKET OVERVIEW

    20.2 MARKET SIZE & FORECAST

    20.3 NORTH AMERICA: PRODUCT SEGMENTATION

    20.4 NORTH AMERICA: MATERIAL SEGMENTATION

    20.5 NORTH AMERICA: BODY PART SEGMENTATION

    20.6 NORTH AMERICA: END-USER SEGMENTATION

    20.7 KEY COUNTRIES

    20.7.1 US: MARKET SIZE & FORECAST

    20.7.2 CANADA: MARKET SIZE & FORECAST

    21 LATIN AMERICA

    21.1 MARKET OVERVIEW

    21.2 MARKET SIZE & FORECAST

    21.3 LATIN AMERICA: PRODUCT SEGMENTATION

    21.4 LATIN AMERICA: MATERIAL SEGMENTATION

    21.5 LATIN AMERICA: BODY PART SEGMENTATION

    21.6 LATIN AMERICA: END-USER SEGMENTATION

    21.7 KEY COUNTRIES

    21.7.1 BRAZIL: MARKET SIZE & FORECAST

    21.7.2 MEXICO: MARKET SIZE & FORECAST

    21.7.3 ARGENTINA: MARKET SIZE & FORECASTS

    22 MIDDLE EAST & AFRICA

    22.1 MARKET OVERVIEW

    22.2 MARKET SIZE & FORECAST

    22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

    22.4 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

    22.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

    22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

    22.7 KEY COUNTRIES

    22.7.1 TURKEY: MARKET SIZE & FORECAST

    22.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST

    22.7.3 SAUDI ARABIA: MARKET SIZE & FORECAST

    22.7.4 EGYPT: MARKET SIZE & FORECAST

    22.7.5 NIGERIA: MARKET SIZE & FORECAST

    23 COMPETITIVE LANDSCAPE

    23.1 COMPETITION OVERVIEW

    23.2 MARKET SHARE ANALYSIS

    24 KEY COMPANY PROFILES

    24.1 ESSITY MEDICAL SOLUTIONS

    24.1.1 BUSINESS OVERVIEW

    24.1.2 ESSITY MEDICAL SOLUTIONS IN ORTHOPEDIC SPLINTS & CASTS MARKET

    24.1.3 PRODUCT OFFERINGS

    24.1.4 KEY STRATEGIES

    24.1.5 KEY STRENGTHS

    24.1.6 KEY OPPORTUNITIES

    24.2 3M

    24.3 ENVOIS

    24.4 BREG

    24.5 DEROYAL INDUSTRIES

    24.6 BAUERFEIND

    25 OTHER PROMINENT VENDORS

    25.1 ALCARE

    25.1.1 BUSINESS OVERVIEW

    25.1.2 PRODUCT OFFERINGS

    25.2 FRANK STUBBS COMPANY

    25.3 WEBER ORTHOPEDIC LP. DBA HELY & WEBER

    25.4 MEDI

    25.5 CAROLINA NARROW FABRIC

    25.6 THUASNE GROUP

    25.7 TRULIFE

    25.8 TYNOR

    25.9 ORTHOSYS

    25.10 DUK-IN

    25.11 PERFORMANCE HEALTH

    25.12 ALIMED

    25.13 LOHMANN & RAUSCHER

    25.14 ELITE ORTHOPAEDICS

    25.15 ALLARD USA

    25.16 BRACEABILITY

    25.17 VISSCO REHABILITATION AIDS

    25.18 BIRD & CRONIN

    25.19 DATT MEDIPRODUCTS

    25.20 PRIME MEDICAL

    26 REPORT SUMMARY

    26.1 KEY TAKEAWAYS

    26.2 STRATEGIC RECOMMENDATIONS

    27 QUANTITATIVE SUMMARY

    27.1 MARKET BY PRODUCT

    27.1.1 APAC: PRODUCT SEGMENTATION

    27.1.2 EUROPE: PRODUCT SEGMENTATION

    27.1.3 NORTH AMERICA: PRODUCT SEGMENTATION

    27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

    27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

    27.2 MARKET BY MATERIAL

    27.2.1 APAC: MATERIAL SEGMENTATION

    27.2.2 EUROPE: MATERIAL SEGMENTATION

    27.2.3 NORTH AMERICA: MATERIAL SEGMENTATION

    27.2.4 LATIN AMERICA: MATERIAL SEGMENTATION

    27.2.5 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

    27.3 MARKET BY BODY PART

    27.3.1 APAC: BODY PART SEGMENTATION

    27.3.2 EUROPE: BODY PART SEGMENTATION

    27.3.3 NORTH AMERICA: BODY PART SEGMENTATION

    27.3.4 LATIN AMERICA: BODY PART SEGMENTATION

    27.3.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

    27.4 MARKET BY END-USERS

    27.4.1 APAC: END USER SEGMENTATION

    27.4.2 EUROPE: END USER SEGMENTATION

    27.4.3 NORTH AMERICA: END USER SEGMENTATION

    27.4.4 LATIN AMERICA: END USER SEGMENTATION

    27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION

    27.5 GEOGRAPHY SEGMENTATION

    27.5.1 CASTS: GEOGRAPHY SEGMENTATION

    27.5.2 SPLINTS: GEOGRAPHY SEGMENTATION

    27.5.3 SYNTHETIC SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

    27.5.4 PLASTER OF PARIS SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

    27.5.5 UPPER BODY: GEOGRAPHY SEGMENTATION

    27.5.6 LOWER BODY: GEOGRAPHY SEGMENTATION

    27.5.7 ORTHOTIC & ORTHOPEDIC CLINICS: GEOGRAPHY SEGMENTATION

    27.5.8 HOSPITALS: GEOGRAPHY SEGMENTATION

    27.5.9 OTHERS: GEOGRAPHY SEGMENTATION

    28 APPENDIX

    28.1 ABBREVIATIONS

    ABOUT US:

    Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

    We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

    Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

    Click Here to Contact Us

    Call: +1-312-235-2040  
    +1 302 469 0707  
    Mail: [email protected]

    Photo: https://mma.prnewswire.com/media/1985732/ORTHOPEDIC_SPLINTS_AND_CASTS_MARKET.jpg
    Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

    Arizton Logo (PRNewsfoto/Arizton Advisory & Intelligence)

    Arizton Logo (PRNewsfoto/Arizton Advisory & Intelligence)

    Cision

    Cision

    View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-printing-revolutionizing-the-orthopedic-splints-and-casts-market-with-tremendous-opportunities-the-market-to-mark-usd-3-34-billion-by-2027–arizton-301724677.html

    SOURCE Arizton Advisory & Intelligence